GT200800203A - Derivados de sulfonil-3-heterociclilindazol como ligandos de 58-hidroxitriptamina-6 - Google Patents

Derivados de sulfonil-3-heterociclilindazol como ligandos de 58-hidroxitriptamina-6

Info

Publication number
GT200800203A
GT200800203A GT200800203A GT200800203A GT200800203A GT 200800203 A GT200800203 A GT 200800203A GT 200800203 A GT200800203 A GT 200800203A GT 200800203 A GT200800203 A GT 200800203A GT 200800203 A GT200800203 A GT 200800203A
Authority
GT
Guatemala
Prior art keywords
hydroxitriptamine
heterociclilindazol
ligandos
sulfonil
derivatives
Prior art date
Application number
GT200800203A
Other languages
English (en)
Inventor
Kevin Liu
Albert Jean Robichaud
Jennifer Rebecca Lo
Hassan Mahmoud Elokdah
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200800203A publication Critical patent/GT200800203A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A COMPUESTOS DE LA FÓRMULA GENERAL I EN LA QUE R,R1,R2,R3,R4,R5,N, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS ACTÚAN COMO LIGANDOS DE LOS RECEPTORES DE 5-HIDROXITRIPTAMINA (5-HT) POR LO QUE SON DE UTILIDAD EN CUADROS DE ALZHEIMER Y PARA EL MEJORAMIENTO DE LA COGNICIÓN.
GT200800203A 2006-04-05 2008-10-02 Derivados de sulfonil-3-heterociclilindazol como ligandos de 58-hidroxitriptamina-6 GT200800203A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78953606P 2006-04-05 2006-04-05

Publications (1)

Publication Number Publication Date
GT200800203A true GT200800203A (es) 2008-12-04

Family

ID=38283536

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200800203A GT200800203A (es) 2006-04-05 2008-10-02 Derivados de sulfonil-3-heterociclilindazol como ligandos de 58-hidroxitriptamina-6

Country Status (17)

Country Link
US (2) US7482461B2 (es)
EP (1) EP2001865A1 (es)
JP (1) JP2009532471A (es)
KR (1) KR20090006148A (es)
CN (1) CN101432274A (es)
AU (1) AU2007235499A1 (es)
BR (1) BRPI0709718A2 (es)
CA (1) CA2648055A1 (es)
CR (1) CR10339A (es)
EC (1) ECSP088789A (es)
GT (1) GT200800203A (es)
IL (1) IL194365A0 (es)
MX (1) MX2008012824A (es)
NO (1) NO20084206L (es)
RU (1) RU2008139078A (es)
WO (1) WO2007117413A1 (es)
ZA (1) ZA200808462B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113527400A (zh) * 2013-04-17 2021-10-22 萨奇治疗股份有限公司 19-去甲c3,3-二取代的c21-n-吡唑基类固醇及其使用方法
EP3845539B1 (en) * 2019-12-31 2022-11-16 Korea Institute of Science and Technology Imidazooxazole derivative having antitumor effect, and pharmaceutical composition including same

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539573A (en) * 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
US4670447A (en) * 1983-08-22 1987-06-02 Hoechst-Roussel Pharmaceuticals Inc. Antipsychotic 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
GB9523250D0 (en) 1995-11-14 1996-01-17 Merck Sharp & Dohme Therapeutic agents
GB9523583D0 (en) 1995-11-17 1996-01-17 Merck Sharp & Dohme Therapeutic agents
AR008245A1 (es) 1996-06-21 1999-12-29 Glaxo Group Ltd Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados
ID23921A (id) 1997-11-04 2000-05-25 Pfizer Prod Inc Penggantian indazola bioisostere katekol pada senyawa-senyawa aktif untuk terapi
NZ525592A (en) 2000-11-02 2004-07-30 Wyeth Corp 1-Aryl- or 1-alkylsufonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
EP1339708A2 (en) 2000-11-20 2003-09-03 Scios Inc. Indole-type inhibitors of p38 kinase
ES2264994T3 (es) 2000-12-22 2007-02-01 Wyeth Compuestos heterociclilalquilindol o -azaindol como ligandos de 5-hidroxitriptamina-6.
IL156517A0 (en) 2000-12-22 2004-01-04 Wyeth Corp Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
TW593278B (en) 2001-01-23 2004-06-21 Wyeth Corp 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
MXPA03009476A (es) 2001-04-20 2004-02-12 Wyeth Corp Derivados de heterocicliloxi-,-tioxi-y-aminobenzazol como ligandos de 5-hidroxitriptamina-6.
MXPA03009490A (es) 2001-04-20 2004-02-12 Wyeth Corp Derivados de heterociclilalcoxi-,-alquiltio-y- alquilaminobenzazol como ligando de 5-hidroxitriptamina-6.
EP1403255A4 (en) 2001-06-12 2005-04-06 Sumitomo Pharma INHIBITORS OF RHO KINASE
WO2003013510A1 (en) 2001-08-07 2003-02-20 Smithkline Beecham P.L.C. 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
US20050113283A1 (en) 2002-01-18 2005-05-26 David Solow-Cordero Methods of treating conditions associated with an EDG-4 receptor
WO2003080608A2 (en) 2002-03-27 2003-10-02 Glaxo Group Limited Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
US7452888B2 (en) 2002-03-27 2008-11-18 Glaxo Group Limited Quinoline derivatives and their use as 5-ht6 ligands
TW200400177A (en) 2002-06-04 2004-01-01 Wyeth Corp 1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
US7943639B2 (en) 2002-06-20 2011-05-17 Proximagen Limited Compounds
TW200401641A (en) 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
TW200403243A (en) 2002-07-18 2004-03-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
WO2004069828A1 (ja) 2003-02-04 2004-08-19 Mitsubishi Pharma Corporation ピペリジン化合物およびその医薬用途
TW200418830A (en) 2003-02-14 2004-10-01 Wyeth Corp Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
PL378120A1 (pl) 2003-02-14 2006-03-06 Wyeth Heterocyklilo-3-sulfonyloindazole jako ligandy 5-hydroksytryptaminy
GB0422263D0 (en) * 2004-10-07 2004-11-10 Glaxo Group Ltd Novel compounds
EP1676841A1 (en) * 2004-12-30 2006-07-05 Esteve Laboratorios Dr. Esteve S.A. Substitited indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their prepartion and use in medicaments

Also Published As

Publication number Publication date
RU2008139078A (ru) 2010-05-10
ZA200808462B (en) 2010-01-27
CA2648055A1 (en) 2007-10-18
IL194365A0 (en) 2009-08-03
WO2007117413A1 (en) 2007-10-18
CN101432274A (zh) 2009-05-13
NO20084206L (no) 2008-10-29
US20090105303A1 (en) 2009-04-23
BRPI0709718A2 (pt) 2011-03-29
US20070238724A1 (en) 2007-10-11
US7482461B2 (en) 2009-01-27
KR20090006148A (ko) 2009-01-14
CR10339A (es) 2008-11-18
ECSP088789A (es) 2008-11-27
MX2008012824A (es) 2008-10-15
EP2001865A1 (en) 2008-12-17
AU2007235499A1 (en) 2007-10-18
JP2009532471A (ja) 2009-09-10

Similar Documents

Publication Publication Date Title
GT200600306A (es) Inhibidores de glutamato agrecanasa
GT200600217A (es) Proceso para la sintesis de compuestos organicos
GT200600430A (es) Compuestos de carboxiamina y metodos de uso de los mismos
GT200600030A (es) 2-fenil-indoles como antagonistas del receptor de la prostaglandina d2
CO6280399A2 (es) Peptidil nitrilos y uso de los mismos como inhibidores de peptidil peptidasa i
GT200600107A (es) Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos
GT200700039A (es) Derivados de triazolopirazina
GT200600181A (es) Derivados de amida sustituida y metodos de uso
GT200500185A (es) Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
GT200500226A (es) Compuestos de aminoheteroarilo sustituidos con pirazol como inhibidores de proteina quinasa
ECSP12012161A (es) Compuestos en calidad de antagonistas de Bradiquinina-b1
ECSP10010722A (es) Compuestos orgánicos
GT200600342A (es) Compuestos de cicloalquilo amino-hidantoina y uso de estos para la modulacion de beta-secretasa
GT200800258A (es) Compuestos de pirrolo-pirimidina y sus usos
CO6321189A2 (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
GT200600164A (es) Derivados de dihidrobenzofuranos y usos de los mismos
GT200500103A (es) 4-fenilamino-quinazolin-6-il-amidas
GT200700077A (es) Compuestos de 4-metilpiridopirimidinona
ECSP088623A (es) Derivados de azepinoindol como agentes farmacéuticos
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
GT200400146A (es) Derivados sustituidos del dioxido de tiazol-benzoisotiazol, procedimiento para su preparacion y su uso
PA8855001A1 (es) Monocarbamas
GT200600208A (es) Compuestos organicos
CR11273A (es) Derivados-2-ona disustituidos en 3, su preparacion y su aplicacion en terapeutica
ECSP109978A (es) Nuevos compuestos